{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:59:24Z","timestamp":1789185564968,"version":"build-2803163510"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Melinta Therapeutics, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,8]]},"DOI":"10.1093\/cid\/ciz006","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T04:24:10Z","timestamp":1550463850000},"page":"S223-S232","source":"Crossref","is-referenced-by-count":20,"title":["Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections"],"prefix":"10.1093","volume":"68","author":[{"given":"Philip A","family":"Giordano","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Orlando Health, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M","family":"Pogue","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Detroit Medical Center, Wayne State University, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Cammarata","sequence":"additional","affiliation":[{"name":"Melinta Therapeutics, Lincolnshire, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"key\n\t\t\t\t2019040801101176000_CIT0001","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/2047-783X-15-12-554","article-title":"Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin","volume":"15","author":"Eckmann","year":"2010","journal-title":"Eur J Med Res"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/1120009X.2017.1311398","article-title":"Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update","volume":"29","author":"Esposito","year":"2017","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0003","first-page":"143","article-title":"Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure","volume":"4","author":"Pulido-Cejudo","year":"2017","journal-title":"Ther Adv Infect Dis"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0004","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/JCM.05817-11","article-title":"Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients","volume":"50","author":"Zervos","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0005","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3201\/eid1509.081228","article-title":"Trends in US hospital admissions for skin and soft tissue infections","volume":"15","author":"Edelsberg","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0006","volume-title":"HCUP facts and figures: statistics on hospital-based care in the United States","author":"Levit","year":"2007"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0007","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.diagmicrobio.2014.02.011","article-title":"Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study","volume":"79","author":"Lipsky","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0008","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jemermed.2014.12.001","article-title":"Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital","volume":"48","author":"Pollack","year":"2015","journal-title":"J Emerg Med"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0009","doi-asserted-by":"crossref","unstructured":"Sulham K , LaPenseeKT, FanW, et al Severity and costs of acute bacterial skin and skin structure infections by treatment setting: an applications of the Eron classification to a real-world database. In: Program and abstracts of the International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting (Montreal, Canada). 2014.","DOI":"10.1016\/j.jval.2014.03.1642"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0010","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3111\/13696998.2015.1078339","article-title":"Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting","volume":"18","author":"Ektare","year":"2015","journal-title":"J Med Econ"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0011","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jamcollsurg.2014.02.039","article-title":"Impact of evolving epidemiology on treatments for complicated skin and skin structure infections: the surgical perspective","volume":"220","author":"Barie","year":"2015","journal-title":"J Am Coll Surg"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0012","volume-title":"Guidance for industry. Acute bacterial skin and skin structure infections: developing drugs for treatment","author":"US Food and Drug Administration","year":"2013"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0013","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00134-006-0517-7","article-title":"Epidemiology of sepsis in Germany: results from a national prospective multicenter study","volume":"33","author":"Engel","year":"2007","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0014","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/497143","article-title":"Practice guidelines for the diagnosis and management of skin and soft-tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0015","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0016","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/648083","article-title":"Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors","volume":"30","author":"Zilberberg","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0017","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/QCO.0000000000000244","article-title":"How to stratify patients at risk for resistant bugs in skin and soft tissue infections","volume":"29","author":"Guillamet","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0018","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1471-2334-12-227","article-title":"A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes","volume":"12","author":"Lipsky","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0019","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.diagmicrobio.2014.02.011","article-title":"Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors","volume":"79","author":"Lipsky","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0020","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s13054-014-0596-8","article-title":"Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in gram-negative severe sepsis and septic shock: a retrospective cohort study","volume":"18","author":"Zilberberg","year":"2014","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0021","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/526444","article-title":"Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections","volume":"29","author":"Edelsberg","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0022","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1021\/jm501881c","article-title":"Origins of the quinolone class of antibacterials: an expanded \u201cdiscovery story.\u201d","volume":"58","author":"Bisacchi","year":"2015","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0023","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0024","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: quinolone resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann NY Acad Sci"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2147\/tcrm.2007.3.2.309","article-title":"Skin and skin structure infections: treatment with newer generation fluoroquinolones","volume":"3","author":"Giordano","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0026","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1093\/jac\/dkx329","article-title":"Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study","volume":"72","author":"Pullman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0027","doi-asserted-by":"crossref","first-page":"e00772","DOI":"10.1128\/AAC.00772-17","article-title":"In vitro activity of delafloxacin and microbiological response against fluoroquinolone-susceptible and nonsusceptible Staphylococcus aureus isolates from two Phase 3 studies of acute bacterial skin and skin structure infections","volume":"61","author":"McCurdy","year":"2017","journal-title":"Antimicrobial Agents Chemother"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0028","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijid.2014.10.009","article-title":"A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections","volume":"30","author":"O\u2019Riordan","year":"2015","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0029","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/jac\/dkv411","article-title":"A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin","volume":"71","author":"Kingsley","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/cid\/ciy165","article-title":"A comparison of the efficacy and safety of intravenous followed by oral delfloxacin with vancomycin plus aztreonam for the treatment of acute bacterial skin and skin structure infections: a phase 3, multinational, double-blind, randomized study","volume":"67","author":"O\u2019Riordan","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0031","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.01201-10","article-title":"Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus","volume":"55","author":"Lemaire","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0032","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2217\/fmb.15.39","article-title":"Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy","volume":"10","author":"Van Bambeke","year":"2015","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0033","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-0012.2006.00608.x","article-title":"Wound complications following kidney and liver transplantation","volume":"20","author":"Mehrabi","year":"2006","journal-title":"Clin Transplant"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0034","doi-asserted-by":"crossref","first-page":"e0143276","DOI":"10.1371\/journal.pone.0143276","article-title":"Rising United States hospital admissions for acute bacterial skin and skin structure infections: recent trends and economic impact","volume":"10","author":"Kaye","year":"2015","journal-title":"PLOS One"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jvs.2015.04.453","article-title":"Predictors of surgical site infection after hospital discharge in patients undergoing major vascular surgery","volume":"62","author":"Wiseman","year":"2015","journal-title":"J Vasc Surg"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0036","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jhin.2013.06.012","article-title":"Obesity and nosocomial infections","volume":"85","author":"Huttunen","year":"2013","journal-title":"J Hosp Infect"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0037","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.amjsurg.2009.12.024","article-title":"Recurrent skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus requiring operative debridement","volume":"201","author":"Sreeramoju","year":"2011","journal-title":"Am J Surg"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0038","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10096-003-0902-x","article-title":"Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis","volume":"22","author":"Carratal\u00e0","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0039","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jinf.2012.03.013","article-title":"Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess","volume":"65","author":"Halilovic","year":"2012","journal-title":"J Infect"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ijo.2012.62","article-title":"Obesity and the risk and outcome of infection","volume":"37","author":"Huttunen","year":"2013","journal-title":"Int J Obes"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0041","doi-asserted-by":"crossref","unstructured":"Ayyagari R , RevolC, TangW, FaustE, TuttleEG. Association of obesity with 30-day readmission rates among patients hospitalized with acute bacterial skin and skin-structure infections (ABSSSI). In: Program and abstracts of the International Society for Pharmacoeconomics 20th Annual International Meeting (Philadelphia, PA). 2015.","DOI":"10.1016\/j.jval.2015.03.1073"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0042","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1592\/phco.27.8.1081","article-title":"Antimicrobial dosing considerations in obese adult patients","volume":"27","author":"Pai","year":"2007","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019040801101176000_CIT0043","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jhm.713","article-title":"Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes","volume":"5","author":"Zilberberg","year":"2010","journal-title":"J Hosp Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/Supplement_3\/S223\/28280479\/ciz006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:23:28Z","timestamp":1606523008000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/Supplement_3\/S223\/5428808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":43,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2019,4,8]]},"published-print":{"date-parts":[[2019,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz006","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,1]]},"published":{"date-parts":[[2019,4,1]]}}}